USANA Health Sciences (USNA) Announces Quarterly Earnings Results

USANA Health Sciences (NYSE:USNA) posted its quarterly earnings data on Tuesday. The company reported $1.11 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.00 by $0.11, Briefing.com reports. The firm had revenue of $273.11 million for the quarter, compared to the consensus estimate of $258.67 million. USANA Health Sciences had a return on equity of 27.02% and a net margin of 5.97%. The business’s revenue for the quarter was up 8.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.87 EPS. USANA Health Sciences updated its FY18 guidance to $4.05-4.45 EPS.

USANA Health Sciences (NYSE USNA) traded down $0.85 during trading hours on Thursday, reaching $74.20. The company’s stock had a trading volume of 156,806 shares, compared to its average volume of 90,426. USANA Health Sciences has a 52 week low of $52.55 and a 52 week high of $79.00. The stock has a market cap of $1,697.47, a PE ratio of 29.44 and a beta of 0.99.

Several research firms have issued reports on USNA. TheStreet downgraded USANA Health Sciences from a “b+” rating to a “c+” rating in a report on Tuesday. Pivotal Research lifted their target price on USANA Health Sciences from $80.00 to $95.00 and gave the company a “buy” rating in a research note on Wednesday. Sidoti cut USANA Health Sciences from a “buy” rating to a “neutral” rating in a research note on Wednesday, January 24th. Finally, BidaskClub cut USANA Health Sciences from a “hold” rating to a “sell” rating in a research note on Thursday, November 2nd.

In other USANA Health Sciences news, major shareholder Global Ltd Gull sold 2,753 shares of USANA Health Sciences stock in a transaction dated Friday, February 2nd. The stock was sold at an average price of $74.24, for a total transaction of $204,382.72. Following the transaction, the insider now owns 11,682,053 shares of the company’s stock, valued at approximately $867,275,614.72. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Myron W. Wentz sold 11,835 shares of USANA Health Sciences stock in a transaction dated Wednesday, November 15th. The shares were sold at an average price of $66.07, for a total value of $781,938.45. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 433,455 shares of company stock worth $28,990,246. Company insiders own 53.20% of the company’s stock.

WARNING: This article was first posted by American Banking News and is owned by of American Banking News. If you are reading this article on another publication, it was stolen and reposted in violation of US & international copyright and trademark laws. The original version of this article can be accessed at https://www.americanbankingnews.com/2018/02/08/usana-health-sciences-usna-announces-quarterly-earnings-results.html.

About USANA Health Sciences

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Earnings History for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply